Rarecyte, Inc.

Seattle, WA

UEI
N6CVCHBTWT86
CAGE
5QC25
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2601 4th Ave #500, Seattle, WA 98121, USA
Website
rarecyte.com
Founded
2009
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Rarecyte, Inc.'s 4 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis… Grant · R44CA298064 National Cancer Institute $1,316,672
Rapid highly multi-plexed immuno-profiling of solid tumors by spectraledge imaging Grant · R44CA224503 National Cancer Institute $3,689,120
Highly multiplexed analysis of solid tumors and liquid tissues by cyclic immunofluorescence Grant · R41CA224503 National Cancer Institute $223,840
Direct visualization assay for detection of b. Burgdorferi in early lyme disease Grant · R43AI113990 National Institutes of Health $598,867

Quick answers

What is Rarecyte, Inc.'s UEI?

Rarecyte, Inc.'s Unique Entity ID (UEI) in SAM.gov is N6CVCHBTWT86.

What is Rarecyte, Inc.'s CAGE code?

Rarecyte, Inc.'s CAGE code is 5QC25.

What is Rarecyte, Inc.'s primary NAICS code?

Rarecyte, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Rarecyte, Inc. located?

Rarecyte, Inc.'s physical address in SAM.gov is 2601 4th Ave #500, Seattle, WA 98121, USA.

Is Rarecyte, Inc. registered in SAM.gov?

Yes. Rarecyte, Inc.'s SAM.gov registration is active through February 2, 2027.

What is Rarecyte, Inc.'s most recent federal award?

Rarecyte, Inc.'s most recent federal grant award is Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis… (R44CA298064), from National Cancer Institute, on June 1, 2025.

On GovTribe

See Rarecyte, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login